Etoposide and Intermediates
|
|
| Etoposide and Intermediates , Etoposide and Intermediates CAS NO 33419-42-0, Product Etoposide and Intermediates
CAS NO 33419-42-0
Standard Enterprise Standard
Molecular Formula C29H32O13
Molecular Weight 588.56
Description white crystal or crystalline powder
Package 25KG/drums
Application anticancer
|
| |
|
Erlotinib and Intermediates
|
|
| Erlotinib and Intermediates , Erlotinib and Intermediates CAS NO 183321-74-6, Product Erlotinib and Intermediates
CAS NO 183321-74-6
Standard Enterprise Standard
Molecular Formula C22H23N3O4
Molecular Weight 393.44
Description white crystal or crystalline powder
Package 25KG/drums
Application anticancer
|
| |
|
Duloxetine and Intermediate
|
|
| Duloxetine and Intermediate, Duloxetine and Intermediate CAS NO 116539-59-4, Product Duloxetine and Intermediates
CAS NO 116539-59-4
Standard BP,USP
Molecular Formula C18H19NOS
Molecular Weight 297.41
Description off-White or white crystal or crystalline powder
Package 25KG/drums
Application Antidepression
|
| |
|
BEPOTASTINE BESILATE and Intermediates
|
|
| BEPOTASTINE BESILATE and Intermediates , BEPOTASTINE BESILATE and Intermediates CAS NO 190786-44-8 , Product BEPOTASTINE BESILATE and Intermediates
CAS NO 190786-44-8
Standard Enterprise Standard
Molecular Formula C27H31ClN2O6S
Molecular Weight 547.07
Description off-White or white crystal or crystalline powder
Package 25KG/drums
Application Antifungal
|
| |
|
Darifenacin hydrobromide and Intermediates
|
|
| Darifenacin hydrobromide and Intermediates , Darifenacin hydrobromide and Intermediates CAS NO 133099-07-7, Product Darifenacin hydrobromide and Intermediates
CAS NO 133099-07-7
Standard Enterprise Standard
Molecular Formula C28H29BrN2O2
Molecular Weight 505.44606
Description off-White or white crystal or crystalline powder
Package 25KG/drums
Application Urinary system
|
| |
|
Levosulpiride and Intermediates
|
|
| Levosulpiride and Intermediates, Levosulpiride and Intermediates CAS NO 23672-07-3, Product Levosulpiride and Intermediates
CAS NO 23672-07-3
Standard BP,USP
Molecular Formula C15H23N3O4S
Molecular Weight 341.43
Description off-White or white crystal or crystalline powder
Package 25KG/drums
Application schizophrenia
|
| |
|
Nateglinide and Intermediates
|
|
| Nateglinide and Intermediates , Nateglinide and Intermediates CAS NO 105816-04-4, Product Nateglinide and Intermediates
CAS NO 105816-04-4
Standard BP,CP,USP
Molecular Formula C19H27NO3
Molecular Weight 317.42
Description White crystal or crystalline powder
Package 25KG/drums
Application antihypertensive
|
| |
|
Policresulen and Intermediates
|
|
| Policresulen and Intermediates , Policresulen and Intermediates CAS NO 101418-00-2, Product Policresulen and Intermediates
CAS NO 101418-00-2
Standard 30% 50%
Molecular Formula C23H24O12S3
Molecular Weight 588.62
Application Antifungal
|
| |
|
Clavulanate Potassium
|
|
| Clavulanate Potassium, Clavulanate Potassium CAS NO 61177-45-5, Product Clavulanate Potassium
CAS NO 61177-45-5
Standard Cp
Molecular Formula C8H8KNO5 237.25
Molecular Weight 237.25
Description off-White crystal or crystalline powder
|
| |
|
Creatine phosphate disodium salt and Intermediates
|
|
| Creatine phosphate disodium salt and Intermediates , Creatine phosphate disodium salt and Intermediates CAS NO 922-32-7 , Product Creatine phosphate disodium salt and Intermediates
CAS NO 922-32-7
Standard Enterprise Standard
Molecular Formula C4H8N3Na2O5P
Molecular Weight 255.08
Description off-White or white crystal or crystalline powder
Package 25KG/drums
Application Cardio-Cerebral -Vascular
|
| |
|
DRONEDARONE HYDROCHLORIDE and Intermediates
|
|
| DRONEDARONE HYDROCHLORIDE and Intermediates , DRONEDARONE HYDROCHLORIDE and Intermediates CAS NO 141625-93-6, Product DRONEDARONE HYDROCHLORIDE and Intermediates
CAS NO 141625-93-6
Standard Enterprise Standard
Molecular Formula C31H44N2O5S.ClH
Molecular Weight 593.224
Description off-White or white crystal or crystalline powder
Package 25KG/drums
Application Anti-arrhythmic drug
|
| |
|
Ciclopirox ethanolamine and Intermediates
|
|
| Ciclopirox ethanolamine and Intermediates , Ciclopirox ethanolamine and Intermediates CAS NO 41621-49-2 , Product Ciclopirox ethanolamine and Intermediates
CAS NO 41621-49-2
Standard Bp，usp
Molecular Formula C14H24N2O3
Molecular Weight 5268.35
Description off-White or white crystal or crystalline powder
Package 25KG/drums
Application Antifungal
|
| |
|
Felodipine and Intermediates
|
|
| Felodipine and Intermediates , Felodipine and Intermediates CAS NO 72509-76-3, Product Felodipine and Intermediates
CAS NO 72509-76-3
Standard EP5.0 USP28 CP2005
Appearance: light yellow to white crystalline powder Melting point:141～145℃ Assay≥99.0％, Total impurity＜1.0％, Individual impurity＜0.5％
Molecular Formula C18H19Cl2NO4
Molecular... |
| |
|
Montelukast sodium and Intermediates
|
|
| Montelukast sodium and Intermediates , Montelukast sodium and Intermediates CAS NO 151767-02-1, Product Montelukast sodium and Intermediates
CAS NO 151767-02-1
Standard CP
Molecular Formula C35H35ClNNaO3S
Molecular Weight 608.17
Description off-White or white crystal or crystalline powder
Package 25KG/drums
Application Respiratory system
|
| |
|
Liranaftate and Intermediates
|
|
| Liranaftate and Intermediates , Liranaftate and Intermediates CAS NO. 88678-31-3, Liranaftate and Intermediates
CAS NO. 88678-31-3
Specification
Purity >99%
Single impurity <0.5%
Capability 50-100KG/M
Status intermittent production
|
| |
|
Nifuratel and Intermediates
|
|
| Nifuratel and Intermediates , Nifuratel and Intermediates CAS NO 4936-47-4, Product Nifuratel and Intermediates
CAS NO 4936-47-4
Standard Enterprise Standard
Molecular Formula C10H11N3O5S
Molecular Weight 285.28
Description off-White or white crystal or crystalline powder
Package 25KG/drums
Application Antifungal
|
| |
|
7-ADCA
|
|
| 7-ADCA, 7-ADCA, 7-ADCA
M.F.: C8H10N2O3S
M.W.: 214.24
Description : White or off-white crystalline powder
Absorbance: ≤0.20
Assay: ≥98.50%
Specific rotation: +155.00°---+168.00°
Delta-2-7-ADCA: ≤0.5%
Loss on drying: ≤0.5% Intermediates of cefradine, cefalexin, cefadroxil
|
| |
|
Naproxen Sodium
|
|
| Naproxen Sodium , Naproxen Sodium , Naproxen Sodium
Introduction:
Clinic use:
(1) Relieve low to medium-grade pain, e.g. from tooth extraction, surgery, functional dysmenorrhea or headache.
(2) Applicable for rheumatoid arthritis, bone arthritis, ankylosing spondylitis, juvenile arthritis, myotenositis, bursitis and acute... |
| |
|
Ondansetron and Intermediates
|
|
| Ondansetron and Intermediates , Ondansetron and Intermediates CAS NO 99614-02-5 , Product Ondansetron and Intermediates
CAS NO 99614-02-5
Standard CP
Molecular Formula C18H20ClN3O
Molecular Weight 329.82
Description off-White or white crystal or crystalline powder
Package 25KG/drums
Application Anti-vomit
|
| |
|
Ramosetron HCL and Intermediates
|
|
| Ramosetron HCL and Intermediates, Ramosetron HCL and Intermediates CAS NO 132907-72-3, Product Ramosetron HCL and Intermediates
CAS NO 132907-72-3
Standard CP
Molecular Formula C17H18ClN3O
Molecular Weight 315.8
Description off-White or white crystal or crystalline powder
Package 25KG/drums
Application Anti-vomit
|
| |
|
Metadoxine and Intermediates
|
|
| Metadoxine and Intermediates , Metadoxine and Intermediates CAS NO 74536-44-0, Product Metadoxine and Intermediates
CAS NO 74536-44-0
Standard Enterprise Standard
Molecular Formula C8H11NO3.C5H7NO3
Molecular Weight 298.293
Description off-White or white crystal or crystalline powder
Package 25KG/drums
Application auxiliary medicine for Liver
|
| |
|
Silodosin and Intermediates
|
|
Prilocaine and Intermediates
|
|
Propiverine hcl and Intermediates
|
|
Lidocaine hcl and Intermediates
|
|
(S)Ropivacaine Hydrochloride
|
|
Bupivacaine HCL and Intermediates
|
|
Imatinib Mesilate and Intermediates
|
|
Pemetrexed disodium hepthydrate and Intermediates
|
|
Pregabalin and Intermediates
|
|
Venlafaxine and Intermediates
|
|
Methyldopa and Intermediates
|
|
Sitagliptin phosphate and Intermediates
|
|
BISOPROLOL HEMIFUMARATE and Intermediates
|
|
Sodium risedronate and Intermediates
|
|
Enalapril maleate and Intermediates
|
|
Strontium ranelate
|
|
Nisoldipine and Intermediates
|
|
Argatroban and Intermediates
|
|
Voriconazole and Intermediates
|
|
Arbidol hydrochloride
|
|
Naproxen
|
|
Racecadotril and Intermediates
|
|
Mefenamic Acid
|
|
Adiphenine hydrochloride
|
|
SECNIDAZOLE and Intermediates
|
|
D-Cycloserine and Intermediates
|
|
Alibendol and Intermediates
|
|
7-ACP
|
|
Indapamide and Intermediates
|
|
Diisopropylammonium dichloroacetate and Intermediates
|
|
Mepivacaine Hcl and Intermediates
|
|
Tamsulosin hcl and Intermediates
|
|
TETRACAINE HCL and Intermediates
|
|
Dexmedetomidine Hcl and Intermediates
|
|
2-Ethoxybenzamide and Intermediates
|
|
Lidocaine and Intermediates
|
|
Granisetron HCL and Intermediates
|
|
BISMUTH POTASSIUM CITRATE and Intermediates
|
|
Tropisetron hcl and Intermediates
|
|
Fudosteine and Intermediates
|
|
Gefitinib and Intermediates
|
|
TETRACAINE and Intermediates
|
|
Cyclophosphamide and Intermediates
|
|
Sulpiride and Intermediates
|
|
Carbidopa and Intermediates
|
|
Risperidal and Intermediates
|
|
Venlafaxine hcl and Intermediates
|
|
Allopurinol and Intermediates
|
|
Bezafibrate and Intermediates
|
|
Levodopa and Intermediates
|
|
Ciprofibrate and Intermediates
|
|
Epalrestat and Intermediates
|
|
IRBESARTAN and Intermediates
|
|
Zoledronic acid and Intermediates
|
|
Iguratimod and Intermediates
|
|
Naftopidil dihydrochloride and Intermediates
|
|
Alendronate sodium and Intermediates
|
|
Leflunomide and Intermediates
|
|
Ipriflavone
|
